The shortcomings of tocilizumab in COVID-19.
Infez Med
; 28(4): 465-468, 2020 Dec 01.
Article
in English
| MEDLINE | ID: covidwho-950599
ABSTRACT
Not available.
Search on Google
Collection:
International databases
Database:
MEDLINE
Main subject:
Interleukin-6
/
Antibodies, Monoclonal, Humanized
/
Cytokine Release Syndrome
/
SARS-CoV-2
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
/
Randomized controlled trials
/
Systematic review/Meta Analysis
Limits:
Humans
Language:
English
Journal:
Infez Med
Journal subject:
Allergy and Immunology
Year:
2020
Document Type:
Article
Affiliation country:
United States
Similar
MEDLINE
...
LILACS
LIS